The unexpected shift towards phentermine, a lower-cost alternative at approximately $5 per month, emerges as a pragmatic response to the host of issues surrounding fulfillment of prescriptions for Wegovy including shortages, supply issues, the expiration of manufacturer coupons, and insurance coverage limitations which impact the accessibility of GLP-1 agonists
GLP-1 inhibitor drugs, originally developed for managing type 2 diabetes, mimic hormones that regulate blood sugar levels, which can help decrease appetite and lower calorie intake
However, when the body breaks it down, a small fraction becomes a toxic byproduct called NAPQI
[8] [22] In December 2024, the FDA revised the indication for tirzepatide (as Zepbound) to include the treatment of moderate to severe obstructive sleep apnea
Companies have thus mistakenly assumed that greater water solubility yields superior bioavailability